iCo Therapeutics Stock Price, News & Analysis (CVE:ICO)

C$0.04 0.00 (0.00 %)
(As of 01/23/2018 03:58 AM ET)
Previous CloseC$0.04
Today's RangeC$0.04 - C$0.05
52-Week RangeC$0.04 - C$0.07
Volume251,000 shs
Average Volume430,888 shs
Market CapitalizationC$3.38 million
P/E Ratio-4.00
Dividend YieldN/A
Beta0.44

About iCo Therapeutics (CVE:ICO)

iCo Therapeutics Inc. (iCo) is a Canada-based biotechnology company principally focused on the identification, development and commercialization of drug candidates to treat sight-and life-threatening diseases. The Company principally focuses on in-licensing drug candidates with a clinical history, and re-dose, reformulate and develop drug candidates for the treatment of sight-and life-threatening diseases. The Company's product candidates include iCo-007, iCo-008 and an Oral AmpB Delivery System. The Company has initiated Phase II clinical trial for iCo-007. iCo-008 is a human monoclonal antibody that is offered to treat sight threatening forms of allergic conjunctivitis by neutralizing eotaxin-1, a ligand to the chemokine receptor CCR3. Oral AmpB Delivery System is a toxic option for the treatment of serious systemic fungal infections. The Company has completed pre-clinical studies for iCo's Oral AmpB Delivery System.

Receive ICO News and Ratings via Email

Sign-up to receive the latest news and ratings for ICO and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry Biotechnology
Sub-IndustryN/A
SectorHealthcare
SymbolCVE:ICO
CUSIPN/A
Phone+1-604-6029414

Debt

Debt-to-Equity RatioN/A
Current RatioN/A
Quick RatioN/A

Price-To-Earnings

Trailing P/E Ratio-4
Forward P/E RatioN/A
P/E GrowthN/A

Sales & Book Value

Annual SalesN/A
Price / SalesN/A
Cash FlowN/A
Price / CashN/A
Book ValueN/A
Price / BookN/A

Profitability

Trailing EPSC($0.01)
Net IncomeN/A
Net MarginsN/A
Return on Equity-85.30%
Return on Assets-77.68%

Miscellaneous

EmployeesN/A
Outstanding Shares84,458,000

iCo Therapeutics (CVE:ICO) Frequently Asked Questions

What is iCo Therapeutics' stock symbol?

iCo Therapeutics trades on the Canadian Venture Exchange (CVE) under the ticker symbol "ICO."

How were iCo Therapeutics' earnings last quarter?

iCo Therapeutics Inc (CVE:ICO) released its earnings results on Friday, May, 30th. The company reported ($0.01) earnings per share (EPS) for the quarter, topping analysts' consensus estimates of ($0.02) by $0.01. View iCo Therapeutics' Earnings History.

When will iCo Therapeutics make its next earnings announcement?

iCo Therapeutics is scheduled to release their next quarterly earnings announcement on Wednesday, April, 18th 2018. View Earnings Estimates for iCo Therapeutics.

Who are some of iCo Therapeutics' key competitors?

Who are iCo Therapeutics' key executives?

iCo Therapeutics' management team includes the folowing people:

  • William W. Jarosz J.D., Independent Chairman of the Board
  • Andrew J. Rae, President, Chief Executive Officer, Director
  • W. John Meekison, Chief Financial Officer, Corporate Secretary
  • Peter Hnik M.D., Chief Medical Officer
  • Richard William Barker, Independent Director
  • Noel F. Hall, Independent Director
  • Douglas Glen Janzen, Independent Director

How do I buy iCo Therapeutics stock?

Shares of iCo Therapeutics and other Canadian stocks can be purchased through online brokerage accounts that support trading on the Toronto Stock Exchange (TSX). Brokers that permit trading on the TSX include Fidelity, Interactive Brokers, PennTrade and Charles Schwab.

What is iCo Therapeutics' stock price today?

One share of iCo Therapeutics stock can currently be purchased for approximately C$0.04.

How big of a company is iCo Therapeutics?

iCo Therapeutics has a market capitalization of C$3.38 million.

How can I contact iCo Therapeutics?

iCo Therapeutics' mailing address is 760-777 Hornby St, VANCOUVER, BC V6Z 1S4, Canada. The company can be reached via phone at +1-604-6029414.


MarketBeat Community Rating for iCo Therapeutics (ICO)

Community Ranking:  2.3 out of 5 (star star)
Outperform Votes:  14 (Vote Outperform)
Underperform Votes:  17 (Vote Underperform)
Total Votes:  31
MarketBeat's community ratings are surveys of what our community members think about iCo Therapeutics and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

iCo Therapeutics (CVE:ICO) Analyst Ratings History


No equities research coverage for this company has been tracked by MarketBeat

Earnings

iCo Therapeutics (CVE:ICO) Earnings History and Estimates Chart

Earnings by Quarter for iCo Therapeutics (CVE:ICO)

iCo Therapeutics (CVE ICO) Earnings History by Quarter

DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
4/18/2018        
5/25/2016Q1 2016C($0.01)ViewN/AView Earnings Details
4/14/2016Q4 2015C($0.01)ViewN/AView Earnings Details
8/26/2015Q2 2015C($0.01)ViewN/AView Earnings Details
8/29/2014Q2 2014C($0.01)C($0.04)ViewN/AView Earnings Details
5/30/2014C($0.02)C($0.01)ViewN/AView Earnings Details
4/24/2014Q4 2013C($0.02)C($0.02)ViewN/AView Earnings Details
11/27/2013Q3 2013C($0.01)ViewN/AView Earnings Details
8/26/2013Q2 2013C($0.01)ViewN/AView Earnings Details
5/29/2013Q1 2013C($0.04)ViewN/AView Earnings Details
4/25/2013Q4 2012C($0.02)ViewN/AView Earnings Details
11/29/2012Q3 2012C($0.02)ViewN/AView Earnings Details
8/29/2012Q2 2012C($0.02)ViewN/AView Earnings Details
5/30/2012Q1 2012C($0.02)ViewN/AView Earnings Details
4/13/2012Q4 2011C($0.01)ViewN/AView Earnings Details
11/18/2011Q3 2011C($0.02)ViewN/AView Earnings Details
8/29/2011Q2 2011C$0.02ViewN/AView Earnings Details
8/27/2010Q2 2010C($0.02)ViewN/AView Earnings Details
11/30/2009Q3 2009C($0.02)ViewN/AView Earnings Details
8/21/2009Q2 2009C($0.02)ViewN/AView Earnings Details
(Earnings results data provided by Zacks Investment Research)

Estimates

iCo Therapeutics (CVE:ICO) Earnings Estimates

No earnings estimates for this company have been tracked by MarketBeat.com

Dividends

Dividend History for iCo Therapeutics (CVE:ICO)


No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Insider Trading History for iCo Therapeutics (CVE ICO)

No insider trades for this company have been tracked by MarketBeat.com

Headlines

iCo Therapeutics (CVE ICO) News Headlines

Source:
No headlines for this company have been tracked by MarketBeat.com

SEC Filings

iCo Therapeutics (CVE:ICO) SEC Filings

This page is loading this company's SEC Filings. Please wait...

Social Media

Financials

Financials are not available for this stock.

Chart

iCo Therapeutics (CVE ICO) Stock Chart for Tuesday, January, 23, 2018

Loading chart…

This page was last updated on 1/23/2018 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.